GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (MEX:PRQR) » Definitions » Policy Acquisition Expense

ProQR Therapeutics NV (MEX:PRQR) Policy Acquisition Expense


View and export this data going back to 2019. Start your Free Trial

What is ProQR Therapeutics NV Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


ProQR Therapeutics NV Business Description

Traded in Other Exchanges
Address
Zernikedreef 9, Leiden, ZH, NLD, 2333 CK
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.